New study of Ebola may hold answers for long-term COVID-19 immunity
The study, carried out in a joint effort by British and Guinean scientists, is the world's largest and most comprehensive one to date to examine survivors of the Ebola virus.
Nano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells leading to activation of T cells to recognize and attack melanoma.(photo credit: PROF. SATCHI-FAINARO)ByTOBIAS SIEGAL
